CLINICAL_TRIALS
trial_result
· 2020-07-23
Clinical Trial Update: Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients [Phase 3]
Summary
Phase 3 trial comparing GP40071 to NovoRapid in type 1 diabetes shows efficacy and safety data after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Geropharm | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED